Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Indonesia
46%
Type 2 Diabetes Mellitus (T2DM)
40%
Rifampicin
33%
Plasma Concentration
31%
Healthy Volunteers
30%
Doxorubicin
30%
Atrial Natriuretic Peptide
30%
Andrographis Paniculata
30%
Clinical Trials
28%
Adverse Drug Reaction
28%
Jakarta
28%
Sprague-Dawley Rats
25%
Cardioprotection
22%
Double-blind Trial
21%
Oxidative Stress
21%
Internal Medicine Wards
20%
Pre-diabetes (pre-DM)
20%
Extracellular Fluid
20%
Colchicine
20%
Myocardial Infarction Patients
20%
ST-elevation Myocardial Infarction (STEMI)
20%
Mangiferin
20%
L-NAME
20%
Angiotensin II (Ang II)
20%
Primaquine
20%
Ritonavir
20%
Placebo
18%
Losartan
18%
Efavirenz
17%
Pioglitazone
17%
Safety Profile
16%
Asian Population
15%
Hematocrit
15%
Hypertension
15%
Drug Administration
15%
Nevirapine
15%
HIV-infected Patients
15%
Enalapril
14%
Renin-angiotensin System
13%
Oxidative Inflammation
13%
NOD-like Receptor Protein 3 (NLRP3)
12%
MRNA Expression
12%
Asian Patients
12%
Non-steroidal Anti-inflammatory Drugs (NSAIDs)
12%
Angiotensin
12%
Retrospective Cohort Study
12%
Ejection Fraction
12%
Prospective Cohort Study
12%
Antioxidant Effect
12%
Nicardipine
11%
Pharmacology, Toxicology and Pharmaceutical Science
Rat
100%
Rifampicin
33%
Adverse Drug Reaction
32%
Clinical Trial
30%
Atrial Natriuretic Factor
30%
Doxorubicin
30%
Normal Human
30%
Sodium
27%
Angiotensin
26%
Sprague Dawley Rat
25%
Angiotensin II
21%
Pharmacokinetics
21%
Primaquine
20%
Ritonavir
20%
Mangiferin
20%
ST Segment Elevation Myocardial Infarction
20%
Colchicine
20%
Maturity Onset Diabetes of the Young
20%
Losartan
18%
Placebo
18%
HIV
17%
Efavirenz
17%
Adverse Event
17%
Myocardial Disease
16%
Drug Administration
16%
Messenger RNA
16%
Inflammation
16%
Renin
16%
Enalapril
15%
Randomized Controlled Trial
15%
Nevirapine
15%
Drug Interaction
14%
Antioxidant
14%
Hypertension
14%
Creatinine
14%
Observational Study
13%
Randomized Clinical Trial
13%
Nicardipine
13%
Retrospective Study
12%
Congestive Heart Failure
11%
Adrenergic Receptor
11%
Lipid
11%
Arginine Methyl Ester
11%
Reperfusion Injury
11%
Controlled Clinical Trial
11%
Cohort Study
11%
Diseases
10%
Combination Therapy
10%
Andrographis paniculata
10%
Breast Cancer
10%